Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04114084 · ClinicalTrials.gov registry record
Sleep Apnea in Patients With MGUS and MM
A clinical trial of Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance, sponsored by Michael Tomasson.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT04114084: Recruiting study of Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance, sponsored by Michael Tomasson.
NCT04114084 is a study of Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance that is actively recruiting participants, run by Michael Tomasson. The registered enrollment target is 200 participants, below the 546-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04114084, a study of Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance, is actively recruiting participants, sponsored by Michael Tomasson.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This study involves patients with plasma cell dyscrasia including monoclonal gammopathy of undetermined significance (MGUS) or multiple myeloma (MM), with and without sleep apnea, who are providing bone marrow specimens. Specimens will be obtained at the time that patients undergo a standard-of-care procedure in order to minimize discomfort and reduce any risk.
Conditions Studied
Interventions
- PROCEDURE Bone Marrow Aspirate and Biopsy
Study Locations (1)
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2019-05-23 |
| Est. Completion | 2030-05-23 |
What NCT04114084 shows while recruiting
NCT04114084 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 546-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (63% lower).
The record links to 2 conditions, with Multiple Myeloma appearing as the primary indexed condition, and to 1 intervention - of which Bone Marrow Aspirate and Biopsy is the first listed.
NCT04114084 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT04114084 about?
NCT04114084 is a clinical study titled "Sleep Apnea in Patients With MGUS and MM". This study involves patients with plasma cell dyscrasia including monoclonal gammopathy of undetermined significance (MGUS) or multiple myeloma (MM), with and without sleep apnea, who are providing bone marrow specimens. Specimens will be obtained at the time that patients undergo a standard-of-care...
What is the current status of trial NCT04114084?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2019-05-23. Estimated completion is 2030-05-23.
What conditions does trial NCT04114084 study?
This clinical trial studies the following conditions: Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance.
What interventions are being tested in trial NCT04114084?
The interventions under investigation include: Bone Marrow Aspirate and Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT04114084?
This trial is sponsored by Michael Tomasson, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04114084 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Myeloma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04114084's enrollment target sits among peer trials
200 110th of 438 higher than 324 of 438 other Multiple Myeloma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Myeloma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant
RECRUITING · Phase 2
-
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
RECRUITING · Phase 1
-
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
RECRUITING · NA
-
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
RECRUITING
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI